Annke Frick

990 total citations
19 papers, 671 citations indexed

About

Annke Frick is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Annke Frick has authored 19 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Annke Frick's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Pancreatic function and diabetes (8 papers). Annke Frick is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Pancreatic function and diabetes (8 papers). Annke Frick collaborates with scholars based in Germany, France and United States. Annke Frick's co-authors include R. H. A. Becker, Klaus Rave, H. Möller, Tim Heise, H. E. Scholtz, Leszek Nosek, Lutz Heinemann, Oliver Klein, Claudia B. Bittner and Robert J. Fountaine and has published in prestigious journals such as Diabetes Care, Clinical Pharmacology & Therapeutics and Thrombosis and Haemostasis.

In The Last Decade

Annke Frick

19 papers receiving 612 citations

Peers

Countries citing papers authored by Annke Frick

Since Specialization

Citations

This map shows the geographic impact of Annke Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annke Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annke Frick more than expected).

Fields of papers citing papers by Annke Frick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annke Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annke Frick. The network helps show where Annke Frick may publish in the future.

Co-authorship network of co-authors of Annke Frick

This figure shows the co-authorship network connecting the top 25 collaborators of Annke Frick. A scholar is included among the top collaborators of Annke Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annke Frick. Annke Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects* 2008 ·Diabetes Obesity and Metabolism ·R. H. A. Becker, Annke Frick, Lenore Teichert, Leszek Nosek, Lutz Heinemann, Tim Heise, Klaus Rave	14
2	Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glulisine 2008 ·Clinical Pharmacokinetics ·R. H. A. Becker, Annke Frick	112
3	Dose–response relationship of insulin glulisine in subjects with type 1 diabetes 2008 ·Diabetes Obesity and Metabolism ·R. H. A. Becker, Annke Frick, Lenore Teichert, Leszek Nosek, Lutz Heinemann, Klaus Rave	2
4	Insulin glulisine: a faster onset of action compared with insulin lispro 2007 ·Diabetes Obesity and Metabolism ·Tim Heise, Leszek Nosek, (unknown), Lutz Heinemann, (unknown), Annke Frick, R. H. A. Becker	69
5	Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes 2007 ·Diabetes Care ·R. H. A. Becker, Annke Frick, Leszek Nosek, Lutz Heinemann, Klaus Rave	26
6	Pharmacokinetics of Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Male Subjects: Pharmacokinetic Model Development for Phase 2/3 Simulation of Exposure 2006 ·The Journal of Clinical Pharmacology ·Anne Paccaly, Annke Frick, Shashank Rohatagi, Jingli Liu, Umesh Shukla, Ronald Rosenburg, Markus Hinder, Bradford K. Jensen	25
7	Anticoagulant and anti-platelet effects are maintained following coadministration of otamixaban, a direct factor Xa inhibitor, and acetylsalicylic acid 2006 ·Thrombosis and Haemostasis ·Markus Hinder, Annke Frick, Ronald Rosenburg, (unknown), Marie‐Laure Ozoux, Volker Laux, (unknown), Alexander Gebauer, Anne Paccaly	6
8	Direct and rapid inhibition of factor Xa by otamixaban: A pharmacokinetic and pharmacodynamic investigation in patients with coronary artery disease 2006 ·Clinical Pharmacology & Therapeutics ·Markus Hinder, Annke Frick, (unknown), Gary W. Hesse, Alexander Gebauer, Jochen Maas, Anne Paccaly	17
9	Pharmacokinetic/Pharmacodynamic Relationships for Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Subjects 2006 ·The Journal of Clinical Pharmacology ·Anne Paccaly, Annke Frick, Marie‐Laure Ozoux, Valeria Chu, Ronald Rosenburg, Markus Hinder, Umesh Shukla, Bradford K. Jensen	7
10	The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin 2006 ·Diabetes Care ·R. H. A. Becker, Sue Sha, Annke Frick, Robert J. Fountaine	51
11	Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes 2006 ·Diabetes Care ·Klaus Rave, Oliver Klein, Annke Frick, R. H. A. Becker	59
12	A Comparison of the Steady-State Pharmacokinetics and Pharmacodynamics of a Novel Rapid-Acting Insulin Analog, Insulin Glulisine, and Regular Human Insulin in Healthy Volunteers Using the Euglycemic Clamp Technique 2005 ·Experimental and Clinical Endocrinology & Diabetes ·R. H. A. Becker, Annke Frick, F J Burger, H. E. Scholtz, (unknown)	34
13	Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes 2005 ·Diabetes Care ·Thomas Danne, R. H. A. Becker, Tim Heise, Claudia B. Bittner, Annke Frick, Klaus Rave	76
14	Insulin Glulisine, a New Rapid-Acting Insulin Analogue, Displays a Rapid Time-Action Profile in Obese Non-Diabetic Subjects 2005 ·Experimental and Clinical Endocrinology & Diabetes ·R. H. A. Becker, Annke Frick, (unknown), (unknown), H. E. Scholtz	73
15	Prospective dose prediction for FXa inhibitor otamixaban (OTAM) using PK/PD simulations accounting for non-dose proportional plasma exposure 2005 ·Clinical Pharmacology & Therapeutics ·Anne Paccaly, Annke Frick, Shashank Rohatagi	1
16	Dependency of the Metabolic Effect of sc-Injected Human Regular Insulin on Intra-abdominal Fat in Patients with Type 2 Diabetes 2004 ·Hormone and Metabolic Research ·Klaus Rave, Leszek Nosek, Lutz Heinemann, Annke Frick, R. H. A. Becker, Christoph Kapitza	4
17	Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers 2003 ·Diabetes & Metabolism ·Klaus Rave, Leszek Nosek, Lutz Heinemann, Annke Frick, R. H. A. Becker	12
18	Biopharmaceutical characterization of oral controlled/modified-release drug products. In vitro/in vivo correlation of roxatidine 1998 ·European Journal of Pharmaceutics and Biopharmaceutics ·Annke Frick, H. Möller, (unknown)	8
19	Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin 1998 ·European Journal of Pharmaceutics and Biopharmaceutics ·Annke Frick, H. Möller, (unknown)	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact